August 2017 Issue Table Of Contents

From The Editor

• Has Your Company Ever Been Held For Ransom?

Feature Articles

• Sanat Chattopadhyay — Shaping Merck’s Manufacturing Future
• Chasing Invention: Jeffrey Kindler At The Helm Of Centrexion
• Ipsen In The USA — Building & Leading The Subsidiary As Startup

Capitol Perspectives

• 340B Reform Gets A Kick Start

Companies To Watch

• ProMIS Neurosciences

CEO Corner

• Collaborating To Stem The Tide Of Emerging Antimicrobial Resistance

Inside The Industry

• Gaining Recognition For A Novel Portfolio — Deal By Deal
• New Hampshire: A Biotech Microhub
• Alternatives To Funding Lower-Priority Trials
• Rising Out Of Takeda’s Reorganization: New Materials & Innovation
• Government Funding And Technology: The Right Ticket For Small Pharma
• How The FDA Views Natural Language Processing

Leadership Lessons

• “Sociopath-Proof” Your Organization: 5 Questions To Ask Today

Ask The Board

• How Will The Biopharma And Services Industry Evolve Over The Next 5 Years?
• How Can I Foster A Culture Of Innovation?
• What Do You See As The Cause Of Declining R&D Productivity?

Reader Feedback

• Reader Feedback